Reuters logo
BRIEF-China Grand Pharmaceutical And Healthcare Gets ‍Drug Clinical Trial Approval Document From China FDA For Products
December 28, 2017 / 10:06 AM / 19 days ago

BRIEF-China Grand Pharmaceutical And Healthcare Gets ‍Drug Clinical Trial Approval Document From China FDA For Products

Dec 28 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd:

* CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS- ‍“BIMATOPROST OPHTHALMIC SOLUTION” OBTAINED DRUG CLINICAL TRIAL APPROVAL DOCUMENT FROM CHINA FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below